Thursday, June 1, 2017

New drug could help people with asthma come off steroid treatment
Trial finds potential reduction of oral steroid use for asthma patients


People who suffer from severe asthma could be looking at a better treatment option thanks to a new drug showing promise.
Right now people with asthma can use an oral steroid, a treatment often associated with long-term side effects. The new drug may have allow patients to reduce how often the steroids are used, ultimately reducing adverse side effects.
The results of the trial were published in the New England Journal of Medicine May 22, highlighting a new medicine and antibody called Benralizumab.
The drug works by blocking the protein that brings a white blood cell called, eosinophil, into the lung.....

Read more here: cbc.ca

------------------------------------------------------

Sensor provides early detection of asthma

Rutgers University researchers have created a sensor that detects nitrite, an important inflammatory biomarker in the inner lining of the respiratory airway, which could lead to earlier detection of asthma attacks and other respiratory conditions.
The graphene-based nanoelectronic sensor measures nitrite in tiny liquid droplets discharged during breathing. Researchers discussed their device in a study published last week in the journal Microsystems & Nanoengineering.....

Read more here: healthdatamanagement.com

------------------------------------------------------

Why managing asthma is critical

I’m sharing this deeply personal story in the hope that it inspires you to act and save a life. To prevent a death from a condition that affects one in nine Australians.
In 2007 my son, Ryan, was enjoying a very full life. He had a beautiful girlfriend, was establishing his career, enjoyed an abundance of friends, loving family and had already traveled abroad. He had plans for his future and was deeply loved.
One Saturday, after playing soccer and spending time with his girlfriend they headed off to a party with friends.....

Read more here: theherald.com.au

No comments: